Glucocorticoid-dependent action of neural crest factor AP-2: Stimulation of phenylethanolamine N-methyltransferase gene expression

Journal of Neurochemistry

Volumn 70, Issue 6, 1998, Pages 2286-2295

  Ebert, Steven N ^a   Ficklin, Mary Beth ^a   Her, Song ^a   Siddall, Brenda J ^a   Bell, Rose Ann ^a   Ganguly, Karunesh ^a   Morita, Kyoji ^a   Wong, Dona L ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Adrenergic expression; AP 2; Glucocorticoids; Phenylethanolamine N methyltransferase gene

Indexed keywords

PHENYLETHANOLAMINE N METHYLTRANSFERASE; TRANSCRIPTION FACTOR AP 2;

ADRENALIN RELEASE; ANIMAL CELL; ARTICLE; GENE EXPRESSION; NEURAL CREST; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; TRANSCRIPTION REGULATION;

ANIMALIA; VERTEBRATA;

EID: 0031775596     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.1998.70062286.x     Document Type: Article

References (40)

1. Anderson D. J. (1993) Cell fate determination in the peripheral nervous system: the sympathoadrenal progenitor. J. Neurobiol. 24, 185-198.
2. Anderson D. J. and Michelson A. M. (1989) Role of glucocorticoids in the chromaffin-neuron developmental decision. Int. J. Dev. Neurosci. 12, 83-94.
3. Bauer R., Imhof A., Pscherer A., Kopp H., Moser M., Seegers S., Kerscher M., Tainsky M., Hofstaedter F., and Buettner R. (1994) The genomic structure of the human AP-2 transcription factor. Nucleic Acids Res. 22, 1413-1420.
4. Bohn M. C. Goldstein M., and Black I. B. (1981) Role of glucocorticoids in the adrenergic phenotype in rat embryonic adrenal aland. Dev. Biol. 82, 1-10.
5. Bruzdzinski C. J., Johnson M. R., Goble C. A., Winograd S. S., and Gelehrter T. D. (1993) Mechanism of glucocorticoid induction of the rat plasminogen activator inhibitor-1 gene in HTC rat hepatoma cells: identification of cis-acting regulatory elements. Mol. Endocrinol. 7, 1169-1177.
6. Buettner R., Kannan P., Imhof A., Bauer R., Yim S., Blockshuber R., Van Dyke M., and Tainksy M. (1993) An alternatively spliced mRNA from the AP-2 gene encodes a negative regulator of transcriptional activation by AP-2. Mol. Cell. Biol. 13, 4174-4185.
7. Cole T., Blendy J., Monaghan A., Krieglstein K., Schmid W., Aguzzi A., Fantuzzi G., Hummler E., Unsicker K., and Schutz G. (1995) Targeted disruption of the glucocorticoid receptor gene blocks adrenergic chromaffin cell development and severely retards lung maturation. Genes Dev. 9, 1608-1621.
8. Diamond M., Miner J. N., Yoshinaga S. K., and Yamamoto K. R. (1990) Transcription factor interactions: selectors of positive or negative regulation from a single DNA element. Science 249, 1266-1272.
9. Duan C. and Clemmons D. (1995) Transcription factor AP-2 regulates human insulin-like growth factor binding protein-5 gene expression. J. Biol. Chem. 270, 24844-24851.
10. Ebert S. and Wong D. (1995) Differential activation of the rat phenylethanolamine N-methyltransferase gene by Sp1 and Egr-1 J. Biol. Chem. 270, 17299-17305.
11. Ebert S. N., Balt S. L., Hunter J. P. B., Gashler A., Sukhatme V., and Wong D. L. (1994) Egr-1 activation of rat adrenal phenylethanolamine N-methyltransferase gene. J. Biol. Chem. 269, 20885-20898.
12. Freedman L. P., Luisi B. F., Korszun Z. R., Basavappa R., Sigler P. B., and Yamamoto K. R. (1988) The function and structure of the metal coordination sites within the glucocorticoid receptor DNA binding domain. Nature 334, 543-546.
13. Funder J. (1992) Glucocorticoid receptors. J. Steroid Biochem. Mol. Biol. 43, 389-394.
14. Gaubatz S., Imhof A., Dosch R., Werner O., Mitchell P., Buettner R., and Eilers M. (1995) Transcriptional activation by myc is under negative control by the transcription factor AP-2. EMBO J. 14, 1508-1519.
15. Greco D., Zellmer E., Zhang Z., and Lewis E. (1995) Transcription factor AP-2 regulates expression of the dopamine β-hydroxylase gene. J. Neurochem. 65, 510-516.
16. Hyman S. E., Comb M., Pearlberg J., and Goodman H. M. (1989) An AP-2 element acts synergistically with the cyclic AMP- and phorbol ester-inducible enhancer of the human proenkephalin gene. Mol. Cell. Biol. 9, 321-324.
17. Kim K.-T., Park D. H., and Joh T. H. (1993) Parallel up-regulation of catecholamine biosynthetic enzymes by dexamethasone in PC12 cells. J. Neurochem. 60, 946-951.
18. Maxam A. M. and Gilbert W. (1977) A new method of sequencing DNA. Proc. Natl. Acad. Sci. USA 74, 5463-5467.
19. Michelson A. M. and Anderson D. J. (1992) Changes in competence determine the timing of two sequential glucocorticoid effects on sympathoadrenal progenitors. Neuron 8, 589-604.
20. Mitchell P. J., Timmons P. M., Hebert J. M., Rigby P. W. J., and Tjian R. (1991) Transcription factor AP-2 is expressed in neural crest cell lineages during mouse embryogenesis. Genes Dev. 5, 105-119.
21. Pearce D. and Yamamoto K. R. (1993) Mineralocorticoid and glucocorticoid receptor activities distinguished by nonreceptor factors at a composite response element. Science 259, 1161-1165.
22. Ross M. E., Evinger M. J., Hyman S. E., Carroll J. M., Mucke L., Comb M., Reis D. J., Joh T. H., and Goodman H. M. (1990) Identification of a functional glucocorticoid response element in the phenylethanolamine N-methyltransferase promoter using fusion genes introduced into chromaffin cells in primary culture. J. Neurosci. 10, 520-530.
23. Schorle H., Meier P., Buchert M., Jaenisch R., and Mitchell P. (1996) Transcription factor AP-2 essential for cranial closure and craniofacial development. Nature 381, 235-238.
24. Seidl K. and Unsicker K. (1989) The determination of the adrenal medullary cell fate during embryogenesis. Dev. Biol. 136, 481-490.
25. Strahle U., Schmid W., and Schutz G. (1988) Synergistic action of the glucocorticoid receptor with transcription factors. EMBO J. 7, 3389-3395.
26. Teitelman G., Baker H., Joh T. H., and Reis D. J. (1979) Appearance of catecholamine-synthesizing enzymes during development of rat sympathetic nervous system: possible role of tissue environment. Proc. Natl. Acad. Sci. USA 76, 509-513.
27. Teitelman G., Joh T. H., Park D., Brodsky M., New M., and Reis D. J. (1982) Expression of the adrenergic phenotype in cultured fetal adrenal medullary cells: role of intrinsic and extrinsic factors. Dev. Biol. 89, 450-459.
28. Tomlinson A., Durbin J., and Coupland R. (1987) A quantitative analysis of rat adrenal chromaffin tissue: morphometric analysis at tissue and cellular level correlated with catecholamine content. Neuroscience 20, 895-904.
29. Williams T. and Tjian R. (1991a) Analysis of the DNA-binding and activation properties of the human transcription factor AP-2. Genes Dev. 5, 670-682.
30. Williams T. and Tjian R. (1991b) Characterization of a dimerization motif in AP-2 and its function in heterologous DNA-binding proteins. Science 251, 1067-1071.
31. Williams T., Admon A., Luscher B., and Tjian R. (1988) Cloning and expression of AP-2, a cell-type-specific transcription factor that activates inducible enhancer elements. Genes Dev. 2, 1557-1569.
32. Winning R., Shea L., Marcus S., and Sargent T. (1991) Developmental regulation of transcription factor AP-2 during Xenopus laevis embryogenesis. Nucleic Acids Res. 19, 3709-3714.
33. Wong D. L., Yamasaki L. L., and Ciaranello R. D. (1987) Characterization of the isozymes of bovine adrenal medullary phenylethanolamine N-methyltransferase. Brain Res. 410, 32-44.
34. Wong D. L., Lesage A., Siddall B., and Funder J. W. (1992a) Glucocorticoid regulation of phenylethanolamine N-methyltransferase in vivo. FASEB J. 6, 3310-3315.
35. Wong D. L., Lesage A., White S., and Siddall B. (1992b) Adrenergic expression in the rat adrenal gland: multiple developmental regulatory mechanisms. Dev. Brain Res. 67, 229-236.
36. Wong D. L., Bildslein C. L., Siddall B., Lesage A., and Yoo Y. S. (1993) Neural regulation of phenylethanolamine N-methyltransferase in vivo: transcriptional and translational changes. Mol. Brain Res. 18, 107-114.
37. Yamamoto K. R. (1985) Steroid regulated transcription of specific genes and gene networks. Annu. Rev. Genet. 19, 721-746.
38. Yang X., Fyodorov D., and Deneris E. (1995) Transcriptional analysis of acetylcholine receptor α3 gene promoter motifs that bind Sp1 and AP-2. J. Biol. Chem. 270, 8514-8520.
39. Yang-Yen H.-F., Chambard J.-C., Sun Y.-L., Smeal T., Schmidt T. J., Drouin J., and Karin M. (1990) Transcriptional interference between c-Jun and the glucocorticoid receptor: mutual inhibition of DNA binding due to direct protein-protein interaction. Cell 62, 1205-1215.
40. Zhang J., Hagopian-Donaldson S., Serbedziha G., Elsemore J., Plehn-Dujowich D., McMahon A., Flavell R., and Williams T. (1996) Neural tube, skeletal and body wall defects in mice lacking transcription factor AP-2. Nature 381, 238-241.